Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- PMID: 27418577
- PMCID: PMC4981759
- DOI: 10.1093/cid/ciw353
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Erratum in
-
Erratum.Clin Infect Dis. 2017 May 1;64(9):1298. doi: 10.1093/cid/ciw799. Clin Infect Dis. 2017. PMID: 28168287 Free PMC article. No abstract available.
-
Erratum.Clin Infect Dis. 2017 Oct 15;65(8):1435. doi: 10.1093/cid/cix587. Clin Infect Dis. 2017. PMID: 29017256 Free PMC article. No abstract available.
-
Erratum.Clin Infect Dis. 2017 Nov 29;65(12):2161. doi: 10.1093/cid/cix759. Clin Infect Dis. 2017. PMID: 29126289 Free PMC article. No abstract available.
Abstract
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia. The panel's recommendations for the diagnosis and treatment of HAP and VAP are based upon evidence derived from topic-specific systematic literature reviews.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
Comment in
-
Reply to Daniels et al.Clin Infect Dis. 2017 Feb 1;64(3):387-388. doi: 10.1093/cid/ciw727. Epub 2016 Nov 1. Clin Infect Dis. 2017. PMID: 27803095 No abstract available.
-
Inhaled Antibiotics for Hospital-Acquired and Ventilator-Associated Pneumonia.Clin Infect Dis. 2017 Feb 1;64(3):386-387. doi: 10.1093/cid/ciw726. Epub 2016 Nov 1. Clin Infect Dis. 2017. PMID: 27803096 No abstract available.
-
Telavancin in the Recent Hospital Acquired and Ventilator Associated Pneumonia (HAP/VAP) 2016 Guidelines.Clin Infect Dis. 2017 Jun 1;64(11):1633. doi: 10.1093/cid/cix272. Clin Infect Dis. 2017. PMID: 28369192 No abstract available.
-
Reply to Hassoun et al.Clin Infect Dis. 2017 Jun 1;64(11):1633-1634. doi: 10.1093/cid/cix275. Clin Infect Dis. 2017. PMID: 28369298 No abstract available.
-
The 2016 Clinical Practice Guidelines for Management of Hospital-Acquired and Ventilator-Associated Pneumonia.Can J Hosp Pharm. 2017 May-Jun;70(3):251-252. doi: 10.4212/cjhp.v70i3.1667. Epub 2017 Jun 30. Can J Hosp Pharm. 2017. PMID: 28680182 Free PMC article. No abstract available.
Similar articles
-
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Clin Infect Dis. 2016 Sep 1;63(5):575-82. doi: 10.1093/cid/ciw504. Clin Infect Dis. 2016. PMID: 27521441 Free PMC article.
-
[Nosocomial pneumonia].Enferm Infecc Microbiol Clin. 2013 Dec;31(10):692-8. doi: 10.1016/j.eimc.2013.04.014. Epub 2013 Jul 1. Enferm Infecc Microbiol Clin. 2013. PMID: 23827827 Spanish.
-
Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study.Crit Care. 2011;15(1):R38. doi: 10.1186/cc9988. Epub 2011 Jan 25. Crit Care. 2011. PMID: 21266065 Free PMC article.
-
Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S48-53. doi: 10.1086/653049. Clin Infect Dis. 2010. PMID: 20597672 Review.
-
Health care-associated pneumonia: identification and initial management in the ED.Am J Emerg Med. 2008 Jul;26(6 Suppl):1-11. doi: 10.1016/j.ajem.2008.03.015. Am J Emerg Med. 2008. PMID: 18603170 Review.
Cited by
-
D-PRISM: a global survey-based study to assess diagnostic and treatment approaches in pneumonia managed in intensive care.Crit Care. 2024 Nov 22;28(1):381. doi: 10.1186/s13054-024-05180-y. Crit Care. 2024. PMID: 39578900 Free PMC article.
-
Effect of metagenomic next-generation sequencing on clinical outcomes in adults with severe pneumonia post-cardiac surgery: a single-center retrospective study.Sci Rep. 2024 Nov 21;14(1):28907. doi: 10.1038/s41598-024-79843-9. Sci Rep. 2024. PMID: 39572618 Free PMC article.
-
Population Pharmacokinetic/Pharmacodynamic Study of Linezolid in Hospital-Acquired Pneumonia Patients with Renal Insufficiency.Drug Des Devel Ther. 2024 Nov 8;18:5073-5086. doi: 10.2147/DDDT.S474470. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39545249 Free PMC article.
-
The Clinical Application Value of a Novel Chip in the Detection of Pathogens in Adult Pneumonia: A Multi-Centre Prospective Study in China.Infect Drug Resist. 2024 Nov 5;17:4843-4852. doi: 10.2147/IDR.S483256. eCollection 2024. Infect Drug Resist. 2024. PMID: 39524976 Free PMC article.
-
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes.Open Forum Infect Dis. 2024 Oct 10;11(11):ofae588. doi: 10.1093/ofid/ofae588. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39512425 Free PMC article.
References
-
- American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388–416. - PubMed
-
- US Food and Drug Administration (FDA). Information for healthcare professionals: colistimethate (marketed as Coly-Mycin M and generic products). Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPa.... Accessed September 2014.
-
- Magill SS, Edwards JR, Fridkin SK;. Emerging Infections Program Healthcare-Associated Infections Antimicrobial Use Prevalence Survey Team. Survey of health care-associated infections. N Engl J Med 2014; 370:2542–3. - PubMed
